Publications by authors named "Zheng-sheng Zou"

Objectives: Non-alcoholic fatty liver disease (NAFLD) is becoming the leading cause of chronic liver disease worldwide. However, treatment of NAFLD is potentially influenced by psychological conditions. Using the simplified version of the University of Rhode Island Change Assessment (URICA-SV) scale, this study aimed to evaluate the stage of psychological change as a prerequisite to refining implementation strategies for psychological change.

View Article and Find Full Text PDF

Background: Early identification of patients with high mortality risk is critical for optimizing the clinical management of drug-induced liver injury (DILI). We aimed to develop and validate a new prognostic model to predict death within 6 months in DILI patients.

Methods: This multicenter study retrospectively reviewed the medical records of DILI patients admitted to three hospitals.

View Article and Find Full Text PDF
Article Synopsis
  • MAIT cells are significantly reduced in patients with alcohol-associated liver disease (ALD) and their loss is linked to specific cell death mechanisms known as pyroptosis.
  • Blood samples from patients reveal that the severity of liver disease correlates with increased pyroptotic MAITs and heightened inflammation markers, indicating a severe immune response.
  • Strategies to inhibit IL-18 signaling may help reduce the activation and death of MAITs, suggesting a potential therapeutic avenue for managing ALD-related complications.
View Article and Find Full Text PDF
Article Synopsis
  • The Chronic Liver Disease Questionnaire for Nonalcoholic Fatty Liver Disease (CLDQ-NAFLD) was translated into Chinese to evaluate its effectiveness in measuring the health-related quality of life (HRQL) among Chinese NAFLD patients.
  • A multicenter study involving 5181 participants confirmed the questionnaire's reliability and validity through various statistical methods, such as Cronbach's alpha and factor analysis.
  • The findings indicate that the Chinese version of CLDQ-NAFLD is a trustworthy tool for assessing HRQL in this patient population.
View Article and Find Full Text PDF

Chronic drug-induced liver injury (DILI) is a rare but under-researched adverse drug reaction-related disease, which is highly likely to progress into liver fibrosis and even cirrhosis. In this study, metabolomics was used to screen out characteristic metabolites related to the histological progression of fibrosis in chronic DILI and analyze the metabolic changes during the development of fibrosis to explain the underlying mechanism. Chronic DILI patients who underwent liver biopsy were divided into different fibrosis grades.

View Article and Find Full Text PDF

Background And Aims: Nonalcoholic fatty liver disease (NAFLD) is associated with metabolic disorders. This study aimed to explore the role of metabolic disorders in screening advanced fibrosis in NAFLD patients.

Methods: A total of 246 histologically-proven NAFLD patients were enrolled across 14 centers.

View Article and Find Full Text PDF

Herbal medicine is widely used in Asia as well as the west. Hepatotoxicity is one of the most severe side effects of herbal medicine which is an increasing concern around the world. (Thunb.

View Article and Find Full Text PDF

Background: This study aimed to assess the association between metabolic syndrome (MetS) and severity of nonalcoholic fatty liver disease (NAFLD), and to discuss the pathological relevance of the diagnostic criteria in metabolic (dysfunction) associated fatty liver disease (MAFLD).

Methods: This was a multicenter, cross-sectional study. Patients with NAFLD confirmed by liver biopsy were enrolled between July 2016 and December 2018 from 14 centers across the mainland of China.

View Article and Find Full Text PDF

Alcohol-associated liver disease (ALD) is caused by alcohol metabolism's effects on the liver. The underlying mechanisms from a metabolic view in the development of alcohol-associated liver cirrhosis (ALC) are still elusive. We performed an untargeted serum metabolomic analysis in 14 controls, 16 patients with ALD without cirrhosis (NC), 27 patients with compensated cirrhosis, and 79 patients with decompensated ALC.

View Article and Find Full Text PDF

Background: Health Related Quality of Life (HRQL) is a multi-dimensional construct that can comprehensively evaluate the patient's health status, including physical, emotional, mental and social well-being. In this study, we aimed to evaluate the impact of non-alcoholic fatty liver disease (NAFLD) on HRQL in a Chinese population.

Methods: In this national multicenter cross-sectional survey, patients with NAFLD were enrolled.

View Article and Find Full Text PDF

Chronic drug-induced liver injury (DILI) occurs in up to 20% of all DILI patients. It presents a chronic pattern with persistent or relapsed episodes and may even progress to cirrhosis. However, its underlying development mechanism is poorly understood.

View Article and Find Full Text PDF

Autoimmune hepatitis (AIH) can progress into severe outcomes, i.e., decompensated cirrhosis, from remarkable and persistent inflammation in the liver.

View Article and Find Full Text PDF

The diagnosis of drug-induced liver injury (DILI) remains a challenge and the cases of Thunb. (PM) induced DILI (PM-DILI) have received much attention This study aimed to identify a simple and high-efficiency approach to PM-DILI diagnosis via metabolomics analysis. Plasma metabolites in 13 PM-DILI patients were profiled by liquid chromatography along with high-resolution mass spectrometry.

View Article and Find Full Text PDF

Idiosyncratic drug-induced liver injury (IDILI) is a rare but potentially severe adverse drug reaction. To date, identifying individuals at risk for IDILI remains challenging. This is a prospective study, where a nested case-control (1:5) design was adopted.

View Article and Find Full Text PDF
Article Synopsis
  • Alcoholic liver disease (ALD) is a serious condition that can lead to complications like cirrhosis and liver cancer, with gMDSCs known to suppress the immune response in liver diseases.
  • A study involving 107 ALD patients and 24 healthy individuals showed that gMDSCs were significantly more abundant in those with alcoholic liver cirrhosis, especially in patients with worse prognosis who also had higher arginase I production.
  • The presence of gMDSCs in both the blood and liver of ALD patients could hinder natural killer cell activity, potentially worsening liver damage and increasing the severity of cirrhosis.
View Article and Find Full Text PDF

Alcohol consumption in China has substantially increased over the last 3 decades and the number of patients with alcoholic liver disease (ALD) is rising at an alarming rate. However, accurate and representative data on time trends in its hospitalization rates are not available. The aim of this study is to assess the current status and burden of ALD in China by analyzing the data from a large tertiary referral hospital, Beijing 302 Hospital.

View Article and Find Full Text PDF

Ethnopharmacological Relevance: Polygonum multiflorum L. is a famous traditional Chinese medicine that has always been perceived to be safe. Recently, the increasing case reports on hepatotoxicity induced by Raw P.

View Article and Find Full Text PDF

Background And Aim: Chinese herbal medicine (CHM), as well as Western medicine (WM), is an important cause of drug-induced liver injury (DILI). However, the differences between CHM and WM as agents implicated in liver injury have rarely been reported.

Methods: Overall, 1985 (2.

View Article and Find Full Text PDF

Objective: To analyze hepatotoxicity of Polygonum multiflorum and clinical character- istics of drug-induced liver injury (DILI) caused by Polygonum multiflorum and its preparations.

Methods: A retrospective study was performed in 158 patients treated at 302 Military Hospital between January 2009 and January 2014. All of them had used Polygonum multiflorum and its preparations before the onset of DILI, and their clinical characteristics and prognoses were analyzed.

View Article and Find Full Text PDF

Primary biliary cholangitis (PBC), previously known as primary biliary cirrhosis, is a model autoimmune disease with chronic cholestasis characterized by the hallmark of anti-mitochondrial antibodies and treated with ursodeoxycholic acid (UDCA). However, approximately 20-40% of patients incompletely respond to UDCA and have an increased risk of disease progression. Although there have been significant advances in the immunobiology of PBC, these have yet to be translated into newer therapeutic modalities.

View Article and Find Full Text PDF

Autoimmune hepatitis (AIH) is often confused with other liver diseases because of their shared nonspecific symptoms and serological and histological overlap. This study compared the plasma metabolomic profiles of patients with AIH, primary biliary cirrhosis (PBC), PBC/AIH overlap syndrome (OS), and drug-induced liver injury (DILI) with those of healthy subjects to identify potential biomarkers of AIH. Metabolomic profiling and biomarker screening were performed using proton nuclear magnetic resonance spectroscopy (H NMR) coupled with a partial least-squares discriminant analysis.

View Article and Find Full Text PDF

Recently traditional Chinese medicine (TCM)-induced liver injury has been an unresolved critical issue which impacts TCM clinical safety. The premise and key step to reduce or avoid drug-induced liver injury (DILI) is to identify the drug source of liver injury in early stage. Then the timely withdrawal of drug and treatment can be done.

View Article and Find Full Text PDF

Myeloid-derived suppressor cells (MDSCs) play an important role in impairing the function of T cells. We characterized MDSCs in two chronic hepatitis C (CHC) cohorts: a cross-sectional group that included 61 treatment-naive patients with CHC, 14 rapid virologic response (RVR) cases and 22 early virologic response (EVR) cases; and a longitudinal group of 13 cases of RVR and 10 cases of EVR after pegylated-interferon-α/ribavirin treatment for genotype 1b HCV infection. Liver samples from 32 CHC patients and six healthy controls were subjected to immunohistochemical analysis.

View Article and Find Full Text PDF

Acute-on-chronic liver failure (ACLF) is a severe life-threatening complication. Liver transplantation is the only available therapeutic option; however, several limitations have restricted its use in patients. The use of corticosteroids as an optional therapy for ACLF has received a great deal of interest.

View Article and Find Full Text PDF

Background: Extensive mononuclear cell infiltration is strongly correlated with liver damage in patients with chronic hepatitis B virus (CHB) infection. Macrophages and infiltrating monocytes also participate in the development of liver damage and fibrosis in animal models. However, little is known regarding the immunopathogenic role of peripheral blood monocytes and intrahepatic macrophages.

View Article and Find Full Text PDF